Signup/Login
If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
Signup/Login
Can you determine which companies are good and which ones - the trash?
Free Pro-version
IPO Filter
Monitor
IPO today
Upcoming IPO
Priced IPO
Solaredge Technologies, Inc. (SEDG)
The Marygold Companies (MGLD)
Blue Water Vaccines (BWV)
Meihua International Medical Technologies (MHUA)
Smart for Life (SMFL)
Vivakor (VIVK)
TC BioPharm Holdings (TCBP)
Direct Digital Holdings, Llc (DRCT)
Modiv (MDV)
Sky Technologies (SKYX)
Modular Medical (MODD)
HeartCore Enterprises (HTCR)
Arcellx, Inc. (ACLX)
Silver Spike Investment Corp. (SSIC)
Maris-Tech Ltd. (MTEK)
Yoshitsu Co., Ltd. (TKLF)
Tpg Inc. (TPG)
Hillstream BioPharma (HILS)
Hour Loop (HOUR)
Vigil Neuroscience, Inc. (VIGL)
More companies

Maravai LifeSciences Holdings, Inc. (MRVI)

Sector - Healthcare

Price chart

N/A
Return from IPO

Company News

IPO Profile

About company

Company Logo
They are a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. Their more than 5,000 customers as of September 30, 2020 include the top 20 global biopharmaceutical companies ranked by research and development expenditures according to industry consultants, and many other emerging biopharmaceutical and life sciences research companies, as well as leading academic research institutes and in vitro diagnostics companies. Their products address the key phases of biopharmaceutical development and include complex nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. Their businesses principally serve high growth market segments in biopharmaceutical development and manufacturing. They estimate that the market segments they serve are growing at a weighted average blended rate of 20% per annum. In particular, the field of cell and gene therapy has emerged as one of the fastest growing treatment modalities to address a host of human conditions.
Industry
Pharmaceuticals
CEO CFO
Carl Hull Kevin Herde
Employees Founded
390 2014

Contacts

Address: 10770 Wateridge Circle Suite 200 San Diego, California 92121

Telephone: (858) 546-0004

Web page: http://www.maravai.com

IPO information

First Trade Date 11/20/2020
Status Priced
Exchange NASDAQ
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range
-
Share prices ($)

Shares & Volumes

Shares Initial (MM) 50
Shares Revised (MM) 60
Expected offer amount (MM) $1275
Realized offer amount(MM) $1620

Financial Data (last reporting year)

Market Cap (MM) $2075.19
Revenues (MM) $221.7
Net Income (Loss) (MM) $59.4

Voting

What do you think will happen with the MRVI share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes: img
The lead left underwriter: Morgan Stanley

IPOs led by the firm .Pro
Profitability of conducted IPOs  ?  .Pro
1st day change  ?  .Pro
Change for the first 3 months  ?  .Pro
Underwriters
Morgan Stanley/ Jefferies/ Goldman Sachs/ BofA Securities/ Credit Suisse/ UBS Investment Bank/ Baird/ William Blair/ Stifel/ KeyBanc Capital
CO-Managers
Academy Securities/ Loop Capital/ Penserra Securities/ Tigress Financial Partners

Sector: Healthcare

Tweets about $MRVI

Tweets volume:

RT volume:

Timeframe:

Google Trends Stats